tiprankstipranks
Trending News
More News >
BrightPath Biotherapeutics Co.Ltd. (JP:4594)
:4594
Japanese Market

BrightPath Biotherapeutics Co.Ltd. (4594) Income Statement

Compare
0 Followers

BrightPath Biotherapeutics Co.Ltd. Income Statement

Last quarter (Q3 2023), BrightPath Biotherapeutics Co.Ltd.'s total revenue was ¥23.00K, a decrease of -99.54% from the same quarter last year. In Q3, BrightPath Biotherapeutics Co.Ltd.'s net income was ¥-399.84M. See BrightPath Biotherapeutics Co.Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
¥ 1.13M¥ 72.00K¥ 5.28M¥ 15.41M¥ 2.50M
Gross Profit
¥ 1.10M¥ -341.00K¥ 3.38M¥ 12.09M¥ 1.36M
Operating Expenses
¥ 1.16B¥ 1.15B¥ 1.47B¥ 1.49B¥ 1.73B
Depreciation and Amortization
¥ 0.00¥ 395.00K¥ 16.72M¥ 35.12M¥ 66.69M
EBITDA
¥ -1.15B¥ -1.17B¥ -1.47B¥ -1.45B¥ -1.65B
Operating Income
¥ -1.16B¥ -1.16B¥ -1.47B¥ -1.48B¥ -1.73B
Other Income/Expenses
¥ 11.67M¥ -11.10M¥ -16.67M¥ -5.74M¥ 15.59M
Pretax Income
¥ -1.15B¥ -1.17B¥ -1.48B¥ -1.48B¥ -1.72B
Net Income
¥ -1.15B¥ -1.17B¥ -1.49B¥ -1.48B¥ -1.72B
Per Share Metrics
Basic EPS
¥ -14.12¥ -18.21¥ -24.90¥ -28.55¥ -36.14
Diluted EPS
¥ -14.12¥ -18.21¥ -24.90¥ -28.55¥ -36.14
Weighted Average Shares Outstanding
81.51M 64.16M 59.66M 51.99M 47.58M
Weighted Average Shares Outstanding (Diluted)
81.51M 64.16M 59.66M 51.99M 47.58M
Currency in JPY

BrightPath Biotherapeutics Co.Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis